Pharmaceutical

Crossject secures funding from French Government for needle-free platform

The cash injection will accelerate the development of Crossject’s prefilled needle free platform to treat anaphylactic shock.

Jul 14, 2024 - 04:00
Crossject secures funding from French Government for needle-free platform
The cash injection will accelerate the development of Crossject’s prefilled needle free platform to treat anaphylactic shock.
Read the original article

Tags:

Previous Article

Microbeads with adaptable fluorescent colors from visible light to near-infrared

Next Article

MSD closes $1.3bn EyeBio acquisition, plans pivotal trial for lead asset

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Voxzogo given green-light to treat children under five by US FDA

Voxzogo given green-light to treat children under five ...

Oct 23, 2023

Magazine: UK’s new Netflix-style funding model for antibiotics goes live

Magazine: UK’s new Netflix-style funding model for anti...

Jun 26, 2024

STAT+: States are ramping up scrutiny of health transactions, as more provider groups look for buyers

STAT+: States are ramping up scrutiny of health transac...

Feb 13, 2024